420 with CNW – One Month In, Medical Marijuana is Doing Wonders for Louisiana Patients

Medical marijuana started being available to certified patients in Louisiana on August 6 and despite a stuttering start, patients are largely happy with what transformations they have experienced after using medical cannabis for their conditions.

Alex Domino, aged 70, was the first patient to buy medical marijuana when it became legal in the state. He says that while he didn’t have any specific expectations of how medical marijuana would change his life, he now admits that…

Read More >>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Acquires Second The+Source Location

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced the closing of its acquisition of Henderson Organic Remedies, LLC (“The+Source Henderson”), which was previously disclosed on December 14, 2018. According to the update, the Henderson location is the second The+Source dispensary operated by GGB in greater Las Vegas, with similar productivity in both locations. “The+Source Henderson has been under our management for the last nine months,” Green Growth Brands CEO Peter Horvath said in the news release. “In that time, we have grown revenue, transactions and gross margin by double digits. Our ability to significantly improve top performing dispensaries, in a market that has seen a significant uptick in competition, is a testament to our expertise in retail operations.”

To view the full press release, visit http://cnw.fm/QAG6w

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD, led by CEO Peter Horvath and a leadership team of consumer-focused retail experts. The company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily and Meri + Jayne, with a licensing agreement with the Greg Norman Brand. Already boasting the strongest sales per square feet in the cannabis industry, GGB is expanding its presence in Nevada, Massachusetts and Arizona with CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGB

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Thailand Turns Confiscated Marijuana into Medical Products

Thailand legalized medical marijuana last year and it started distributing cannabis oil in state-run hospitals last week. Now the Thai authorities have announced that they will be turning over any seized illegal marijuana to the government agency making cannabis oil for distribution in government-run hospitals.

This week, the police confiscated one ton of marijuana from a criminal gang. Rather than destroy this bust, the Thai authorities have made a decision to transfer the marijuana to the Department of Traditional Alternative Medicine as well as…

Read More >>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – NIDA Unveils Cannabis Research Priority List

In a notice that was published on Wednesday, the National Institute on Drug Abuse (NIDA) provided a list of the areas that it considers a priority for marijuana research to focus on. These research objectives show that the federal government is taking note of the increasing levels of success that are being registered by advocates who want to see U.S. marijuana law reform.

NIDA observes that the pace at which marijuana policy reform is taking place outpaces the rate at which knowledge is becoming available to help countries around the world to ascertain how the public health effects of the marijuana policy changes can be assessed.

When the list of 13 priorities is analyzed, it is apparent that the federal agency has decided to be broad-minded as it seeks to understand the wave of cannabis legalization across the country. For example, the agency doesn’t just want to know what effects cannabis has, but also wants to learn why people take to medical marijuana and continue using it.

Some of the other objectives listed in the notice of special interest include developing standards that can be followed while measuring the dosage, impairment and intoxication by cannabis.

Another objective seeks to understand how using marijuana alongside or in substitution of other substances, such as alcohol, prescription and non-prescription drugs, tobacco affects health outcomes. The NIDA notice calls this “polysubstance use.”

The federal agency also wants to know how marijuana industry practices, such as marketing, taxes and product prices impact the health outcomes of cannabis use. From this research objective, one can read that NIDA wants to find out whether cannabis industry players are doing anything to make access to marijuana easier, and whether anything can be done (through taxes, for example) to make the drug less accessible.

Of interest to NIDA are the different policies and systems under which marijuana distribution is done in various jurisdictions across the U.S. Which combination of policies and practices offers the best ways to minimize the potential harms of marijuana to the public?

The recent months have seen a number of federal agencies publish notices of marijuana research funding opportunities. In fact, in May this year NIDA advertised a position which to all intents and purposes required someone who would prepare and analyze cannabis rolls/joints for research purposes.

Industry watchers believe that marijuana industry actors like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Green Hygienics Holdings Inc. (OTCQB: GRYN)  will view this newly published notice authored by NIDA as a sign that the federal government may be considering how to reform its marijuana policies without taking too many chances on matters of public health.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Florida Legislator Files Marijuana Decriminalization Bill

Rep. Shevrin Jones (D) has filed a bill in the Florida Assembly seeking to decriminalize the possession of up to 20grams of marijuana. This bill comes at a time when campaigners who wish to have marijuana legalized through a ballot measure have collected and submitted the number of voter signatures required before the Supreme Court of the state can review the language of their petition.

In a press release, Jones said that he was pleased to file this bill as a way to fix the broken criminal justice system of the state. The existing marijuana laws have disproportionately affected people of color who end up losing their student financial aid, access to housing loans, denial of job opportunities and so many other collateral effects of having a marijuana possession conviction on one’s criminal record. Jones adds that he is proud to introduce this law which will put an end to more Floridians being adversely affected by these laws which are implemented in a selective manner.

The bill also makes the possession of less than 600miligrams of THC a non-criminal offense that is punishable by a fine rather than jail time.

Marijuana law reform advocacy groups, such as NORML, have welcomed this new bill saying that Florida has a reputation of having some of the most draconian marijuana laws in the country, so any measure that pegs back those punitive policies will provide much needed relief. NORML pledged to support the legislator in any way they can to ensure that the draft legislation passes in both legislative chambers of the state.

Meanwhile, it isn’t yet clear whether marijuana will be legalized in Florida since attempts to do so legislatively failed and the push to refer the matter to voters is still in its infancy.

However, some jurisdictions within the state have taken matters into their own hands and they are initiating local laws decriminalizing low-level marijuana possession. Cocoa Beach for example approved a measure in May to decriminalize the possession of less than 20grams of cannabis. Tallahassee is also likely to do the same if the efforts of one local lawmaker spearheading a decriminalization drive achieve the desired outcome.

As all this is going on, the state police has admitted that the legalization of industrial hemp has made it harder to prosecute marijuana possession cases. Police officers have therefore been advised to be extra vigilant so that they don’t prosecute people for marijuana-related crimes when those people had hemp, a plant that looks like marijuana but doesn’t cause any psychoactive effects.

Industry analysts believe that cannabis industry players like Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) could be wondering when the federal government will reform its marijuana policies so that the fragmented reforms being seen in different states can come to an end.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cannabis Flavonoids Could Trigger Another Medical Marijuana Revolution

Just as skeptics were beginning to grudgingly acknowledge that marijuana’s cannabinoids do have medical benefits, a new wave or revolution is about to start if new research into the painkilling effects of the flavonoids unique to cannabis is anything to go by. A team of Canadian researchers has found that two flavonoids found in cannabis could be 30 times more powerful than aspirin, without the adverse effects associated with the conventional painkiller.

The work of these scientists seems poised to open another front in the medicinal potential of the cannabis plant which is enjoying growing popularity as the decades of prohibition get reversed in several states and jurisdictions.

Many plants have flavonoids, and these compounds give those plants their unique pigmentation. These compounds protect plants from diseases and UV radiation, and they also attract pollinators to the flowers of the plants.

More importantly, flavonoids have anti-inflammatory effects, and that is why many so-called superfoods are hailed as beneficial to people with inflammation in their bodies. The Canadian scientists have identified specific flavonoids that are only present in marijuana, and they have called them Cannaflavins.

Of particular interest is Cannaflavin A and Cannaflavin B which appear to be 30 times more potent than aspirin. Their healing effects were first hinted at by scientists at the University of London back in 1980.

However, there seems to be one major hurdle in the way of tapping the therapeutic value of these cannaflavins. These compounds occur in such small amounts that it could be hard to extract them in a way that makes economic sense.

This is where the work of the Canadian scientists comes in. The team, led by Tariq Akhtar (an assistant professor in the department of molecular and cellular biology at Guelph University), has developed and patented a novel technique through which the genes responsible for the formation of Cannaflavin A and B can be identified.

Their method then uses that genetic information to metabolically engineer the properties of those genes so that the therapeutic compounds can be obtained without having to grow vast amounts of cannabis plants.

The scientists have a lot of hope in these cannaflavins since they deal with inflammation at its source without any adverse effects. They therefore hope to conduct more research into these compounds now that the regulatory environment in Canada is supportive of such research.

Cannabis industry analysts believe that industry players like Green Hygienics Holdings Inc. (OTCQB: GRYN) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) could be very pleased because of the Guelph University research that shows there is still so much more that cannabis can offer in the medical arena.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Can the Pechoti Method Apply to Weed as Well?

Pecho…what? If you are hearing about the Pechoti method for the first time, you aren’t alone, although this mode of administration of alternative remedies isn’t new. It entails putting drops of essential oils on the belly button as a way of treating different conditions, including PMS, nausea and pain. Now some people have been suggesting that one can ingest cannabis oil in this way. But is this even possible?

What the Pechoti Method Is

As mentioned earlier, the Pechoti method refers to an old Ayurveda treatment method in which essential oils are dropped onto the belly button to combat different conditions.

The Pechoti method derives its name from the Pechoti gland which is said to exist right behind the belly button. This gland remains in existence even if an infant’s umbilical cord is cut, and the gland remains throughout one’s life, according to the believers in this method of treatment.

The advocates of this method reason that once a human is formed in the womb, all the nutrition goes through the umbilical cord until the baby is born. They argue that if a baby could entirely depend on what is coming through the umbilical cord, why shouldn’t an adult continue using this vital part?

How It Works

Doctors who believe in this treatment method, like Dr. Lakisha Jenkins, say that approximately 72,000 veins pass through the umbilical cord and continue to all parts of the body. This means that any oil that is placed on the belly button is eventually absorbed and circulated throughout the body.

Dr. Jenkins adds that the gastrointestinal tract contains multiple cannabinoid receptors. The gut also plays a critical role in our immune system as well as the central nervous system. When cannabis oil is applied to the belly button, it navigates its way to the whole body through the veins that pass through the belly button.

Who Should Use this Method?

Proponents of the Pechoti method say that it works in the same way as suppositories since both are systemic (work on the whole body rather than the small part where they are applied). Since the cannabis oil administered in this way isn’t metabolized in the liver, a user cannot get high.

Consequently, kids and people who are so ill that they cannot smoke marijuana or ingest it orally can benefit from the Pechoti method.

People with endocrine system disorders, nervous system problems, gastrointestinal issues and those with neurological complaints are some of the people who can try using the Pechoti method to administer their cannabis oil treatment.

However, the effectiveness of the Pechoti method for using cannabis oil is subject to one condition; one must use organic oil from a trusted source so that the risk of impurities entering your bloodstream is avoided.

Analysts believe that the cannabis industry players like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP), must be amazed at how creative people have become in coming up with different ways to ingest cannabis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Waves of CBD Beauty Products Filling Shelves of Major Retailers Across the US

CannabisNewsWire Editorial Coverage: Mainstream retailers across the United States are embracing the growing popularity of the nonpsychoactive cannabinoid, cannabidiol (CBD), making room for CBD products on their prominent shelves.

With the rise of these cannabis beauty products, major stores from luxury retailers Barney’s and Neiman Marcus down to Walgreens, Rite Aid and now Kroger are stocking products from a range of CBD SKU producers, including Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) (GGBXF Profile), Charlotte’s Web Holdings (TSX: CWEB) (OTCQX: CWBHF), CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST), Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) (OGI Profile) and..

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – 6 Highlights of Michigan’s Newly Released Recreational Marijuana Rules

More than half a year after Michigan voters approved a ballot measure to legalize recreational marijuana, the authorities have released emergency rules which will shape the recreational industry in the state. Here are some of key takeaways from those rules.

Local Authorities Have Until Nov. 1 to Opt Out of Hosting Cannabis Businesses

State authorities will start accepting recreational marijuana business license applications on Nov. 1 this year. Until that date, local authorities (townships and cities) can make up their minds whether they will or will not allow marijuana businesses to operate within their jurisdictions. Currently, 600 communities have opted out, but many of those were waiting to review the rules released by the state government before making a final decision on the matter.

Social Use is in the Offing

The state plans to issue special licenses to establishments that wish to have the social consumption of pot on their premises. However, those social consumption lounges will not be allowed to sell food or alcohol. If organizers of festivals and special events apply for a permit, marijuana consumption will also be allowed at such gatherings. Industry analysts wonder what industry players like Green Hygienics Holdings Inc. (OTCQB: GRYN) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) would make of this provision given the fact that marijuana lounges won’t be allowed to sell food or alcohol, but cannabis can be availed at festivals (where food and alcohol are also available).

Starting a Recreational Cannabis Business Will Be Easier Than Starting a Medical Cannabis Business

It will be easier for those interested in starting recreational pot business when compared to the requirements for starting a medical cannabis company. For example, those opening recreational cannabis businesses will not be required to prove that they have funds while those who start medical cannabis companies have to prove that they have between $200,000 and $500,000 in cash and assets before obtaining a license. It is also more affordable to get a license to grow recreational marijuana than get one for growing medical marijuana.

One Store Can Sell Both Medical and Recreational Marijuana

The emergency rules also have clauses allowing medical cannabis provisioning centers to sell recreational marijuana as well if the two types of products are stored or displayed in different sections of the store. The entrance and points-of-sale systems can be the same for both types of buyers.

Medical Cannabis Plants May Be Transferred to Recreational Marijuana Grow Facilities

In the beginning, plants originally cultivated for the medical marijuana market may be transferred to a facility cultivating weed for the recreational market. This provision has been created in order to minimize supply kinks as recreational marijuana sales are launched.

A Plan for Social Equity in the Industry is Being Drafted

The state authorities have also indicated they will release a social equity plan later this month (July) outlining how communities which were hit hard during the days of cannabis prohibition can be supported to benefit from the legal industry. This support could include license fee waivers.

On paper, these rules seem logical and practical enough, but the true test will come once their implementation begins later this year before recreational sales begin next year.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – CBD Shows Promise in Study on Superbugs

As bugs get more resistant to the existing antibiotics, researchers are looking for new ways to combat infections and cannabidiol, a marijuana compound, is showing promise as a remedy for superbugs.

A new study conducted by researchers in Brisbane, Australia has shown that CBD has promising antimicrobial activity against some strains of Gram-positive bacteria, such as varieties of strep and staph bacteria.

In the study, a synthetic form of CBD was placed in lab dishes containing the bugs being investigated. The cannabis compound showed the same level of antimicrobial activity as two existing prescription antibiotics (daptomycin and vancomycin). The synthetic CBD even went as far as killing some strains of strep and staph bacteria that no longer responded to the two prescription antibiotics.

Additionally, the synthetic compound also acted against bacterial biofilms. These biofilms are formed when proteins are secreted by bacteria on surfaces. Such surfaces can become slippery, and the resulted infections are very difficult to treat. The in vitro tests showed that CBD can combat such biofilms.

The researchers have cautioned that people should not start treating themselves against infections using CBD since this research was an in vitro (in test tubes) study and the findings aren’t a guarantee that similar results will be observed in humans.

Mark Blaskovich, the lead author of the study, said that people are better off sticking to the current treatment options against infections until such a time when their preliminary research findings are pursued further and confirm that CBD works effectively to fight infections in humans.

The study was conducted as a collaboration between Botanix Pharmaceuticals (a drug discovery company) and the Center for Superbug Solutions at the University of Queensland in Brisbane, Australia.

While the research is yet to be published in a peer-reviewed journal, it was presented on June 23 to the American Society for Microbiology during its annual meeting in San Francisco.

It is still early days before CBD is developed into a drug for infections. As already mentioned, further research is needed to establish at what dosage CBD can combat infections in humans, how best to administer the compound for maximum effect, and what side effects, if any, may result from the use of CBD as an antibiotic at the therapeutic dosage established.

The authors of this study are now set on conducting animal studies on the antibacterial activity of CBD while Botanix Pharmaceuticals has set its sights on studying whether CBD can be used to kill staph bacteria on the skin of people before they undergo surgery. This step is essential in preventing post-surgical infections.

Industry watchers expect the entire cannabis industry, including players like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP), to feel vindicated by the proof emerging about the health benefits of different marijuana compounds.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com